Published in J Clin Immunol on December 24, 2011
Pregnancy and infection. N Engl J Med (2014) 4.15
Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol (2013) 1.01
Perinatal depression--the fourth inflammatory morbidity of pregnancy?: Theory and literature review. Psychoneuroendocrinology (2013) 1.00
Host immune status and response to hepatitis E virus infection. Clin Microbiol Rev (2014) 0.96
Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. Proc Natl Acad Sci U S A (2014) 0.95
Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation (2013) 0.91
Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies. Clin Vaccine Immunol (2013) 0.89
The role of environmental factors in modulating immune responses in early life. Front Immunol (2014) 0.88
PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats. Reprod Toxicol (2014) 0.86
Maternal vaccination for the prevention of influenza: current status and hopes for the future. Expert Rev Vaccines (2016) 0.84
Distribution and biomarker of carbon-14 labeled fullerene C60 ([(14) C(U)]C60 ) in pregnant and lactating rats and their offspring after maternal intravenous exposure. J Appl Toxicol (2015) 0.81
Suppression of natural killer cell cytotoxicity in postpartum women: time course and potential mechanisms. Biol Res Nurs (2013) 0.81
The role of KIR and HLA interactions in pregnancy complications. Immunogenetics (2017) 0.81
Association of polymorphisms in natural killer cell-related genes with preterm birth. Am J Epidemiol (2013) 0.80
Mapping the Fetomaternal Peripheral Immune System at Term Pregnancy. J Immunol (2016) 0.78
Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine. J Infect Dis (2015) 0.78
Characterization of B cells in healthy pregnant women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth (2016) 0.78
Arsenic exposure and hepatitis E virus infection during pregnancy. Environ Res (2015) 0.78
Influenza pathogenicity during pregnancy in women and animal models. Semin Immunopathol (2016) 0.78
Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype. Proc Natl Acad Sci U S A (2016) 0.76
An AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimester. PLoS One (2014) 0.75
Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study. PLoS One (2016) 0.75
Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting. J Acquir Immune Defic Syndr (2017) 0.75
Reply: Maternal vaccination: moving the science forward. Hum Reprod Update (2015) 0.75
Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy. J Infect Dis (2016) 0.75
Arsenic and Immune Response to Infection During Pregnancy and Early Life. Curr Environ Health Rep (2017) 0.75
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today (1993) 8.00
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 6.54
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol (1998) 4.29
Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol (1959) 3.22
Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80
Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol (1993) 2.65
The immune system in pregnancy: a unique complexity. Am J Reprod Immunol (2010) 2.33
Defensins in innate antiviral immunity. Nat Rev Immunol (2006) 2.26
Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol (1958) 2.02
Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg (2003) 1.92
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG (2000) 1.88
Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis (2002) 1.82
Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol (2001) 1.75
Suppression of B lymphopoiesis during normal pregnancy. J Exp Med (1993) 1.48
Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol (2010) 1.37
NK cells and human pregnancy--an inflammatory view. Trends Immunol (2006) 1.30
Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol (1999) 1.29
The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol (2007) 1.20
Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol (1998) 1.18
The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ (2010) 1.10
Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol (2010) 1.08
The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol (2003) 1.07
Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol (2002) 1.04
Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev (2000) 1.01
The effects of the 1918-1919 influenza pandemic on infant and child health in Derbyshire. Med Hist (2005) 1.01
Cell-mediated immunity and pregnancy. Chest (1984) 0.99
Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol (2003) 0.98
Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leukoc Biol (1996) 0.98
Pandemic influenza and pregnancy: a call for preparedness planning. Obstet Gynecol (2007) 0.97
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J Leukoc Biol (2007) 0.93
SARS during pregnancy, United States. Emerg Infect Dis (2004) 0.93
Listeriosis. Pediatr Infect Dis J (2003) 0.90
Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol (2011) 0.85
Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes. Am J Reprod Immunol Microbiol (1987) 0.82
Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation. Br J Haematol (1994) 0.79
Phenotypic and functional evaluation of suppressor cells in normal pregnancy and in chronic aborters. Cell Immunol (1986) 0.79
Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol (1995) 0.76
Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol (1995) 0.75
Langerhans cells arise from monocytes in vivo. Nat Immunol (2006) 5.46
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med (2004) 5.07
Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog (2010) 3.89
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect (2008) 3.11
Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94
Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol (2010) 2.76
Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab (2002) 2.69
The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep (2008) 2.65
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med (2006) 2.53
The effects of hypertension and body mass index on cognition in schizophrenia. Am J Psychiatry (2010) 2.33
Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study. Lancet (2011) 2.24
"Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster responders. Am J Ind Med (2010) 2.21
Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J Exp Med (2003) 2.20
Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. J Exp Med (2006) 2.18
Burden of asthma in inner-city elementary schoolchildren: do school-based health centers make a difference? Arch Pediatr Adolesc Med (2003) 2.18
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol (2004) 2.10
Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis (2003) 2.05
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc Natl Acad Sci U S A (2003) 1.91
A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol (2012) 1.90
Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe (2010) 1.89
Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol (2009) 1.84
Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone). Am J Cardiol (2002) 1.81
The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol (2005) 1.77
PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS (2007) 1.75
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Am Heart J (2003) 1.74
Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol (2005) 1.73
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Endocrine disruptors and childhood social impairment. Neurotoxicology (2010) 1.71
MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. J Immunol (2008) 1.68
Validity of pre-eclampsia registration in the medical birth registry of norway for women participating in the norwegian mother and child cohort study, 1999-2010. Paediatr Perinat Epidemiol (2014) 1.58
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J Infect Dis (2005) 1.54
Meeting standards of high-quality intensive care unit palliative care: clinical performance and predictors. Crit Care Med (2012) 1.52
A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol (2006) 1.51
Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect (2016) 1.50
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Multiple myeloma in World Trade Center responders: a case series. J Occup Environ Med (2009) 1.49
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma. J Rheumatol (2005) 1.46
Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med (2010) 1.43
Communication about chronic critical illness. Arch Intern Med (2007) 1.42
Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res (2007) 1.40
Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol (2010) 1.37
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol (2007) 1.35
Attitudes toward working on interdisciplinary healthcare teams: a comparison by discipline. J Am Geriatr Soc (2002) 1.32
Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog (2008) 1.32
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog (2011) 1.28
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
The virion host shutoff protein of herpes simplex virus 1 blocks the replication-independent activation of NF-κB in dendritic cells in the absence of type I interferon signaling. J Virol (2011) 1.26
The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study. Pediatrics (2004) 1.25
Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest (2005) 1.25
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells. J Virol (2012) 1.21
The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr (2003) 1.19
Maternal ethnicity and pre-eclampsia in New York City, 1995-2003. Paediatr Perinat Epidemiol (2011) 1.17
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2008) 1.16
Prenatal exposure to environmental phenols: concentrations in amniotic fluid and variability in urinary concentrations during pregnancy. Environ Health Perspect (2013) 1.16
The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells. PLoS One (2010) 1.15
Characteristics of patients requesting and receiving physician-assisted death. Arch Intern Med (2003) 1.14
The influence of pregnancy on systemic immunity. Immunol Res (2012) 1.14
Cytokine-independent upregulation of MDA5 in viral infection. J Virol (2007) 1.13
Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology. Environ Health Perspect (2015) 1.13
Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J Gen Virol (2005) 1.11
Neonatal genome-wide methylation patterns in relation to birth weight in the Norwegian Mother and Child Cohort. Am J Epidemiol (2014) 1.11
Maternal ethnic ancestry and adverse perinatal outcomes in New York City. Am J Obstet Gynecol (2009) 1.10
In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect (2011) 1.10
Opioid treatment for agitation in patients with advanced dementia. Int J Geriatr Psychiatry (2003) 1.09
Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study. J Allergy Clin Immunol (2011) 1.08
p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol (2011) 1.08
Haplotype-phenotype relationships of paraoxonase-1. Cancer Epidemiol Biomarkers Prev (2005) 1.07
Total laparoscopic hysterectomy versus da Vinci robotic hysterectomy: is using the robot beneficial? J Gynecol Oncol (2011) 1.07
A novel model of demyelinating encephalomyelitis induced by monocytes and dendritic cells. J Immunol (2006) 1.06
Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes. Nucleic Acids Res (2005) 1.06
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine (2009) 1.05
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial. Hum Vaccin Immunother (2014) 1.05
Kernel machine SNP-set testing under multiple candidate kernels. Genet Epidemiol (2013) 1.04
Personnel standards and quality assurance practices of biochemical genetic testing laboratories in the United States. Arch Pathol Lab Med (2003) 1.04
Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum Immunol (2007) 1.03
Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J Virol (2006) 1.03
Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis (2012) 1.03